CDTX vs DG · rev $1.3M vs P/E 15, rev $40.61B
Cidara Therapeutics Inc (CDTX) versus Dollar General Corporation (DG) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Dollar General Corporation (DG) is a discount stores company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported DG revenue for 2025-01-31 was $40.61B. Net income was $1.13B. Revenue was up 5.0% from 2024-02-02 to 2025-01-31. DG currently screens at market cap $22.87B and trailing P/E 14.7.
CDTX currently screens at market cap $6.96B. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Not investment advice. Open the CDTX and DG stock pages for the full models.
Not investment advice.